Baxter Nicholas W has filed 4 insider transactions across 1 company since July 2023.
Most recent transaction: a grant/award of 11000 shares of Lexaria Bioscience Corp. ($LEXX) on May 15, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Lexaria Bioscience Corp. | $LEXX | Baxter Nicholas W | Director | A | Stock Options | 11000 | $0.00 | 248,200.0000 | 0 | 4.64% | 0.00% |
| July 26, 2024 | Lexaria Bioscience Corp. | $LEXX | Baxter Nicholas W | Director | A | Stock Options | 12000 | $0.00 | 185,200.0000 | 0 | 6.93% | 0.00% |
| April 26, 2024 | Lexaria Bioscience Corp. | $LEXX | Baxter Nicholas W | Director | A | Stock Options | 5000 | $0.00 | 133,200.0000 | 0 | 3.90% | 0.00% |
| July 25, 2023 | Lexaria Bioscience Corp. | $LEXX | Baxter Nicholas W | Director | A | Stock Options | 5000 | $0.00 | 93,200.0000 | 0 | 5.67% | 0.00% |